Search Results - "BARTSCH, Rupert"

Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC) by Berghoff, Anna Sophie, Ricken, Gerda, Wilhelm, Dorothee, Rajky, Orsolya, Widhalm, Georg, Dieckmann, Karin, Birner, Peter, Bartsch, Rupert, Preusser, Matthias

“…Brain metastases (BM) are frequent in small cell lung cancer (SCLC). Novel insights into their pathobiology are needed for development of better therapies. We…”
Get full text

Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients by Petricevic, Branka, Laengle, Johannes, Singer, Josef, Sachet, Monika, Fazekas, Judit, Steger, Guenther, Bartsch, Rupert, Jensen-Jarolim, Erika, Bergmann, Michael

“…Monoclonal antibodies (mAb), such as trastuzumab are a valuable addition to breast cancer therapy. Data obtained from neoadjuvant settings revealed that…”
Get full text

Trastuzumab administration during pregnancy: a systematic review and meta-analysis by Zagouri, Flora, Sergentanis, Theodoros N., Chrysikos, Dimosthenis, Papadimitriou, Christos A., Dimopoulos, Meletios-Athanassios, Bartsch, Rupert

“…Landmark studies have established trastuzumab in the treatment of HER2-positive breast cancer. The present systematic review and meta-analysis aims to…”
Get full text

Molecularly targeted therapies in cervical cancer. A systematic review by Zagouri, Flora, Sergentanis, Theodoros N, Chrysikos, Dimosthenis, Filipits, Martin, Bartsch, Rupert

“…Abstract Cervical cancer represents the third most common cause of female cancer mortality. Even with the best currently available treatment, a significant…”
Get full text

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria by Deutschmann, Christine, Bartsch, Rupert, Singer, Christian F, Gschwantler-Kaulich, Daphne, Seifert, Michael, Leser, Carmen, Marhold, Maximilian, Bago-Horvath, Zsuzsanna, Pfeiler, Georg

“…Abstract Purpose IMpassion130 led to the approval of atezolizumab plus nab-paclitaxel as first-line treatment for patients with unresectable locally advanced…”
Get full text

Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy by Spick, Claudio, Bickel, Hubert, Pinker, Katja, Bernathova, Maria, Kapetas, Panagiotis, Woitek, Ramona, Clauser, Paola, Polanec, Stephan H., Rudas, Margaretha, Bartsch, Rupert, Helbich, Thomas H., Baltzer, Pascal A.

“…Diffusion‐weighted MRI (DWI) provides insights into tissue microstructure by visualization and quantification of water diffusivity. Quantitative evaluation of…”
Get full text

Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine by Knöbl, Viktoria, Maier, Lukas, Grasl, Stefan, Kratzer, Carmen, Winkler, Felix, Eder, Vanessa, Hayden, Hubert, Sahagun Cortez, Maria Amparo, Sachet, Monika, Oehler, Rudolf, Frantal, Sophie, Fesl, Christian, Zehetner, Karin, Pfeiler, Georg, Bartsch, Rupert, Fitzal, Florian, Singer, Christian F, Filipits, Martin, Gnant, Michael, Brostjan, Christine

“…Monocytes comprise subsets of classical, intermediate and non-classical monocytes with distinct anti- or pro-tumor effects in breast cancer (BC). They are…”
Get full text

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer by Marhold, Maximilian, Udovica, Simon, Halstead, Anna, Hirdler, Mona, Ferner, Muna, Wimmer, Kerstin, Bago-Horvath, Zsuzsanna, Exner, Ruth, Fitzal, Florian, Strasser-Weippl, Kathrin, Robinson, Tim, Bartsch, Rupert

“…Based upon results of the KEYNOTE-522 trial and following approval by regulatory authorities, the addition of pembrolizumab to chemotherapy is now the…”
Get full text

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients by Wimmer, Kerstin, Sachet, Monika, Ramos, Cristiano, Frantal, Sophie, Birnleitner, Hanna, Brostjan, Christine, Exner, Ruth, Filipits, Martin, Bago-Horvath, Zsuzsanna, Rudas, Margaretha, Bartsch, Rupert, Gnant, Michael, Singer, Christian F., Balic, Marija, Egle, Daniel, Oehler, Rudolf, Fitzal, Florian

“…Abstract Background Epirubicin/cyclophosphamide (EC) and docetaxel (D) are commonly used in a sequential regimen in the neoadjuvant treatment of early,…”
Get full text

Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients by Kowalczyk, Lidia, Bartsch, Rupert, Singer, Christian F., Farr, Alex

“…The human epidermal growth factor receptor 2 (HER2) is commonly associated with poor prognosis and is overexpressed in approximately 15-20% of all breast…”
Get full text

Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology by Onesti, Concetta Elisa, Tagliamento, Marco, Curigliano, Giuseppe, Harbeck, Nadia, Bartsch, Rupert, Wildiers, Hans, Tjan-Heijnen, Vivianne, Martin, Miguel, Rottey, Sylvie, Generali, Daniele, Campone, Mario, Cristofanilli, Massimo, Pusztai, Lajos, Peeters, Marc, Berchem, Guy, Cortes, Javier, Ruhstaller, Thomas, Ciruelos, Eva, Rugo, Hope S, Jerusalem, Guy

“…The COVID-19 pandemic has affected healthcare systems globally, leading to reorganization of medical activities. We performed an international survey aimed to…”
Get full text

mTOR inhibitors in breast cancer: A systematic review by Zagouri, Flora, Sergentanis, Theodoros N, Chrysikos, Dimosthenis, Filipits, Martin, Bartsch, Rupert

“…Abstract PI3K/AKT/mTOR pathway is a crucial mediator of tumor progression. As the PI3K/Akt pathway is heavily deregulated in breast cancer, the application of…”
Get full text

Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group by Dubsky, Peter C, Jakesz, Raimund, Mlineritsch, Brigitte, Pöstlberger, Sabine, Samonigg, Hellmut, Kwasny, Werner, Tausch, Christoph, Stöger, Herbert, Haider, Karin, Fitzal, Florian, Singer, Christian F, Stierer, Michael, Sevelda, Paul, Luschin-Ebengreuth, Gero, Taucher, Susanne, Rudas, Margaretha, Bartsch, Rupert, Steger, Günther G, Greil, Richard, Filipcic, Lidija, Gnant, Michael

“…Anastrozole (ANA) alone delivers significant disease-free survival benefits over tamoxifen (TAM) monotherapy in postmenopausal women with early estrogen…”
Get full text

Prevalence and biopsychosocial indicators of fatigue in cancer patients by Zeilinger, Elisabeth L., Zrnic‐Novakovic, Irina, Oppenauer, Claudia, Fellinger, Matthäus, Knefel, Matthias, Unseld, Matthias, Wagner, Theresa, Lubowitzki, Simone, Bartsch, Rupert, Zöchbauer‐Müller, Sabine, Raderer, Markus, Staber, Philipp B., Valent, Peter, Gaiger, Alexander

“…Introduction Symptoms of cancer‐related fatigue (CRF) can have a significant impact on patients' quality of life and treatment adherence. We aimed to…”
Get full text

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial) by Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Petzer, Andreas, Burgstaller, Sonja, Fuchs, David, Rossmann, Dieter, Balic, Marija, Egle, Daniel, Rumpold, Holger, Singer, Christian F, Bartsch, Rupert, Petru, Edgar, Melchardt, Thomas, Ulmer, Hanno, Mlineritsch, Brigitte, Greil, Richard

“…Triple-negative breast cancer (TNBC) comprises a heterogeneous group of diseases which are generally associated with poor prognosis. Up to now, no targeted…”
Get full text

Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT by Steger, Guenther G., Egle, Daniel, Bartsch, Rupert, Pfeiler, Georg, Petru, Edgar, Greil, Richard, Helfgott, Ruth, Marth, Christian, Öhler, Leopold, Hubalek, Michael, Lang, Alois, Tinchon, Christoph, Haslbauer, Ferdinand, Redl, Andreas, Hock, Karin, Hennebelle, Mathias, Mraz, Bernhard, Gnant, Michael

“…STEPAUT, an Austrian non-interventional study, evaluated the safety and efficacy of everolimus plus exemestane in patients with hormone receptor-positive…”
Get full text

Capecitabine and Trastuzumab in Heavily Pretreated Metastatic Breast Cancer by BARTSCH, Rupert, WENZEL, Catharina, ALTORJAI, Gabriela, PLUSCHNIG, Ursula, RUDAS, Margaretha, MADER, Robert M, GNANT, Michael, ZIELINSKI, Christoph C, STEGER, Guenther G

“…In human epidermal growth factor 2 (HER-2)-positive advanced breast cancer, taxanes or vinorelbine plus trastuzumab are among the most widely applied options…”
Get full text

Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients by Berghoff, Anna S, Bartsch, Rupert, Preusser, Matthias, Ricken, Gerda, Steger, Guenther G, Bago-Horvath, Zsuzsanna, Rudas, Margareta, Streubel, Berthold, Dubsky, Peter, Gnant, Michael, Fitzal, Florian, Zielinski, Christoph C, Birner, Peter

“…Abstract Background Recently, HER3-expression was postulated as independent risk factor for metastatic spread. Therefore, we investigated the role of HER3…”
Get full text

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study by Obermeier, Hanna L., Riedl, Julia, Ay, Cihan, Koder, Silvia, Quehenberger, Peter, Bartsch, Rupert, Kaider, Alexandra, Zielinski, Christoph C., Pabinger, Ingrid

“…Unlabelled Box Cancer‐associated venous thromboembolism (VTE) is an important complication in the course of a malignant disease. Low ADAMTS‐13 (a…”
Get full text

The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies by Gaiger, Alexander, Lubowitzki, Simone, Krammer, Katharina, Zeilinger, Elisabeth L., Acel, Andras, Cenic, Olivera, Schrott, Andrea, Unseld, Matthias, Rassoulian, Anahita Paula, Skrabs, Cathrin, Valent, Peter, Gisslinger, Heinz, Marosi, Christine, Preusser, Matthias, Prager, Gerald, Kornek, Gabriela, Pirker, Robert, Steger, Günther G., Bartsch, Rupert, Raderer, Markus, Simonitsch‐Klupp, Ingrid, Thalhammer, Renate, Zielinski, Christoph, Jäger, Ulrich

“…Objective We aimed to investigate whether (1) psychological and social indicators influence survival in patients diagnosed with cancer or haematologic…”
Get full text